Cancer Treatment

Electrical engineer works on personalizing medical treatment

Published in Gene Therapy Weekly, November 3rd, 2005

As cancer remains a leading cause of death in the United States, early detection and treatment are critical keys to improving the survival rate. Yet, an individual's response to treatment varies considerably, even among cancers of the same histological type. Given these variables, individualized patient assessment becomes a very challenging procedure.

Virginia Tech's Yue (Joseph) Wang, who currently leads a $5.5 million research effort to improve the outcome for breast cancer patients, dreams of a more personalized medicine in which doctors can precisely determine how a patient's cancer will behave. Then, based on the expected outcomes the physician can target a precise...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2005-11-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry